Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01681745 · ClinicalTrials.gov registry record · NA
Probe Configuration and Time-Temperature Dose Ranging for Understanding of Skin Lesion Effects
A NA study of Histological Response of Tissue to Cold, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01681745: Completed NA study of Histological Response of Tissue to Cold, sponsored by Pacira Pharmaceuticals.
NCT01681745 is a NA study of Histological Response of Tissue to Cold that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01681745, a NA study of Histological Response of Tissue to Cold, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to characterize the biological response of the epidermis, dermis and subcutaneous tissue to treatment with the Myoscience Cryo-Touch III system.
Primary Outcome
The biological response of the treated tissue by the Cryo-Touch III or Cryo-Touch IV device was determined through gross pathology and histological assessment.
Conditions Studied
Interventions
- DEVICE Cryo-Touch III
Study Locations (1)
California
- 77 Plastic Surgery - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-06-01 |
| Est. Completion | 2015-04-01 |
| Phase | NA |
What the finished NCT01681745 record still lists
NCT01681745 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Histological Response of Tissue to Cold appearing as the primary indexed condition, and to 1 intervention - of which Cryo-Touch III is the first listed.
NCT01681745 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01681745 about?
NCT01681745 is a clinical study titled "Probe Configuration and Time-Temperature Dose Ranging for Understanding of Skin Lesion Effects". This study is designed to characterize the biological response of the epidermis, dermis and subcutaneous tissue to treatment with the Myoscience Cryo-Touch III system.
What is the current status of trial NCT01681745?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2012-06-01. Estimated completion is 2015-04-01.
What conditions does trial NCT01681745 study?
This clinical trial studies the following conditions: Histological Response of Tissue to Cold.
What interventions are being tested in trial NCT01681745?
The interventions under investigation include: Cryo-Touch III (DEVICE).
Who is sponsoring clinical trial NCT01681745?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01681745 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01681745's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI